10-Q Filing

LifeMD, Inc. CIK: 948320 Q3 2014

Filing Information

Form Type	10-Q
Accession Number	`0001213900-14-008234`
Period End Date	20140930
Filing Date	20141114
Fiscal Year	2014
Fiscal Period	Q3
XBRL Instance	immd-20140930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 44 Income Statement 60 Cash Flow Statement 44 Stockholders Equity 11

Balance Sheet 44 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$46.65K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$90.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	30.73M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$155.06K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$98.93K	USD	Point-in-time
Trade accounts receivable	`AccountsReceivableNetCurrent`	$110.62K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	30.73M	shares	Point-in-time
Trade accounts receivable	`AccountsReceivableNetCurrent`	$77.47K	USD	Point-in-time
Legal settlement proceeds receivable	`LegalSettlementProceedsReceivable`	$132.00K	USD	Point-in-time
Legal settlement proceeds receivable	`LegalSettlementProceedsReceivable`	-	USD	Point-in-time
Inventory	`InventoryNet`	$54.87K	USD	Point-in-time
Inventory	`InventoryNet`	$86.19K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$255.49K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$450.73K	USD	Point-in-time
Furnishings and equipment	`PropertyPlantAndEquipmentNet`	$100.72K	USD	Point-in-time
Furnishings and equipment	`PropertyPlantAndEquipmentNet`	$57.99K	USD	Point-in-time
Total Assets	`Assets`	$551.45K	USD	Point-in-time
Total Assets	`Assets`	$313.48K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$259.14K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$185.36K	USD	Point-in-time
Deposit payable	`DepositPayable`	$100.00K	USD	Point-in-time
Deposit payable	`DepositPayable`	-	USD	Point-in-time
Notes payable	`NotesPayable`	$40.20K	USD	Point-in-time
Notes payable	`NotesPayable`	$67.20K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$326.34K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$325.56K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$30.40K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$17.50K	USD	Point-in-time
Total Liabilities	`Liabilities`	$343.84K	USD	Point-in-time
Total Liabilities	`Liabilities`	$355.96K	USD	Point-in-time
Common stock, $0.01 par value; 50,000,000 shares authorized, 30,729,973 shares issued and outstanding at September 30, 2014	`CommonStockValue`	$301.05K	USD	Point-in-time
Common stock, $0.01 par value; 50,000,000 shares authorized, 30,729,973 shares issued and outstanding at September 30, 2014	`CommonStockValue`	$307.30K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$7.96M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$8.04M	USD	Point-in-time
Accumulated (deficit)	`RetainedEarningsAccumulatedDeficit`	$-8.38M	USD	Point-in-time
Accumulated (deficit)	`RetainedEarningsAccumulatedDeficit`	$-8.06M	USD	Point-in-time
Total Stockholders' (Deficit) Equity	`StockholdersEquity`	$-30.36K	USD	Point-in-time
Total Stockholders' (Deficit) Equity	`StockholdersEquity`	$195.49K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$551.45K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$313.48K	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Sales	`Revenues`	$554.51K	USD	3 Qtrs
Sales	`Revenues`	$647.84K	USD	3 Qtrs
Sales	`Revenues`	$94.68K	USD	1 Quarter
Sales	`Revenues`	$165.47K	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$177.13K	USD	3 Qtrs
Cost of sales	`CostOfRevenue`	$42.37K	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$189.85K	USD	3 Qtrs
Cost of sales	`CostOfRevenue`	$71.61K	USD	1 Quarter
Gross Profit	`GrossProfit`	$52.31K	USD	1 Quarter
Gross Profit	`GrossProfit`	$364.66K	USD	3 Qtrs
Gross Profit	`GrossProfit`	$470.70K	USD	3 Qtrs
Gross Profit	`GrossProfit`	$93.86K	USD	1 Quarter
Compensation and related expenses	`CompensationAndRelatedExpenses`	$429.38K	USD	3 Qtrs
Compensation and related expenses	`CompensationAndRelatedExpenses`	$102.17K	USD	1 Quarter
Compensation and related expenses	`CompensationAndRelatedExpenses`	$151.33K	USD	1 Quarter
Compensation and related expenses	`CompensationAndRelatedExpenses`	$380.15K	USD	3 Qtrs
Professional fees	`ProfessionalFees`	$104.16K	USD	3 Qtrs
Professional fees	`ProfessionalFees`	$20.13K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$32.20K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$112.79K	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$43.28K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$98.68K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$208.44K	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$246.00K	USD	3 Qtrs
Operating (Loss)	`OperatingIncomeLoss`	$-385.96K	USD	3 Qtrs
Operating (Loss)	`OperatingIncomeLoss`	$-168.67K	USD	1 Quarter
Operating (Loss)	`OperatingIncomeLoss`	$-259.61K	USD	3 Qtrs
Operating (Loss)	`OperatingIncomeLoss`	$-132.94K	USD	1 Quarter
License Fee	`LicenseCosts`	$-25.00K	USD	1 Quarter
License Fee	`LicenseCosts`	$-25.00K	USD	1 Quarter
License Fee	`LicenseCosts`	$-50.00K	USD	3 Qtrs
License Fee	`LicenseCosts`	$-50.00K	USD	3 Qtrs
Other income	`OtherIncome`	-	USD	1 Quarter
Other income	`OtherIncome`	-	USD	3 Qtrs
Other income	`OtherIncome`	$7.88K	USD	3 Qtrs
Other income	`OtherIncome`	-	USD	1 Quarter
Interest (expense)	`InterestExpense`	$259.00	USD	1 Quarter
Interest (expense)	`InterestExpense`	$1.17K	USD	3 Qtrs
Interest (expense)	`InterestExpense`	-	USD	3 Qtrs
Interest (expense)	`InterestExpense`	-	USD	1 Quarter
Net (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-329.25K	USD	3 Qtrs
Net (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-108.20K	USD	1 Quarter
Net (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-209.61K	USD	3 Qtrs
Net (Loss) Before Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-143.67K	USD	1 Quarter
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-12.90K	USD	3 Qtrs
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-12.90K	USD	3 Qtrs
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-4.30K	USD	1 Quarter
Deferred income tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-4.30K	USD	1 Quarter
Net (Loss)	`NetIncomeLoss`	$-196.71K	USD	3 Qtrs
Net (Loss)	`NetIncomeLoss`	$-103.90K	USD	1 Quarter
Net (Loss)	`NetIncomeLoss`	$-139.37K	USD	1 Quarter
Net (Loss)	`NetIncomeLoss`	$-316.35K	USD	3 Qtrs
Basic and diluted (loss) per share	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Basic and diluted (loss) per share	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	3 Qtrs
Basic and diluted (loss) per share	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	3 Qtrs
Basic and diluted (loss) per share	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.25M	shares	3 Qtrs
Average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	29.19M	shares	3 Qtrs
Average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	30.38M	shares	1 Quarter
Average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	29.41M	shares	1 Quarter

Cash Flow Statement 44 line items

Line Item	Tag	Value	Unit	Period
Net (Loss)	`NetIncomeLoss`	$-196.71K	USD	3 Qtrs
Net (Loss)	`NetIncomeLoss`	$-103.90K	USD	1 Quarter
Net (Loss)	`NetIncomeLoss`	$-139.37K	USD	1 Quarter
Net (Loss)	`NetIncomeLoss`	$-316.35K	USD	3 Qtrs
Depreciation	`Depreciation`	$42.73K	USD	3 Qtrs
Depreciation	`Depreciation`	$42.73K	USD	3 Qtrs
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-12.90K	USD	3 Qtrs
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-12.90K	USD	3 Qtrs
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-4.30K	USD	1 Quarter
Deferred tax benefit	`DeferredIncomeTaxExpenseBenefit`	$-4.30K	USD	1 Quarter
Stock compensation expense	`ShareBasedCompensation`	$52.50K	USD	3 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$10.00K	USD	3 Qtrs
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	3 Qtrs
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$-80.50K	USD	3 Qtrs
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-38.38K	USD	3 Qtrs
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$33.15K	USD	3 Qtrs
Legal settlement proceeds receivable	`IncreaseDecreaseInLegalSettlement`	$-132.00K	USD	3 Qtrs
Legal settlement proceeds receivable	`IncreaseDecreaseInLegalSettlement`	-	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-31.33K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$56.67K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$73.78K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$20.19K	USD	3 Qtrs
Net cash provided (used) by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-112.48K	USD	3 Qtrs
Net cash provided (used) by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$7.95K	USD	3 Qtrs
Investment in Adiuvo Investment S. A.	`PaymentsToAcquireInterestInJointVenture`	$100.00K	USD	3 Qtrs
Investment in Adiuvo Investment S. A.	`PaymentsToAcquireInterestInJointVenture`	-	USD	3 Qtrs
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$-50.00K	USD	3 Qtrs
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	-	USD	3 Qtrs
Notes payable, net	`RepaymentsOfNotesPayable`	$-10.20K	USD	3 Qtrs
Notes payable, net	`RepaymentsOfNotesPayable`	$-27.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$60.20K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$27.00K	USD	3 Qtrs
Net (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-65.05K	USD	3 Qtrs
Net (decrease) in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-52.28K	USD	3 Qtrs
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$46.65K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$90.00K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$155.06K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$98.93K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$46.65K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$90.00K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$155.06K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$98.93K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaid`	$515.00	USD	3 Qtrs
Cash paid during the period for interest	`InterestPaid`	-	USD	3 Qtrs

Stockholders Equity 11 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-30.36K	USD	Point-in-time
Balance	`StockholdersEquity`	$195.49K	USD	Point-in-time
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	-	USD	3 Qtrs
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$-80.50K	USD	3 Qtrs
Amortization of stock options	`AmortizationOfESOPAward`	$10.00K	USD	3 Qtrs
Net (loss)	`NetIncomeLoss`	$-196.71K	USD	3 Qtrs
Net (loss)	`NetIncomeLoss`	$-103.90K	USD	1 Quarter
Net (loss)	`NetIncomeLoss`	$-139.37K	USD	1 Quarter
Net (loss)	`NetIncomeLoss`	$-316.35K	USD	3 Qtrs
Balance	`StockholdersEquity`	$-30.36K	USD	Point-in-time
Balance	`StockholdersEquity`	$195.49K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.